Cargando…
TXNIP inhibition in the treatment of type 2 diabetes mellitus: design, synthesis, and biological evaluation of quinazoline derivatives
Thioredoxin interacting protein (TXNIP) is a potential drug target for type 2 diabetes mellitus (T2DM) treatment. A series of quinazoline derivatives were designed, synthesised, and evaluated to inhibit TXNIP expression and protect from palmitate (PA)-induced β cell injury. In vitro cell viability a...
Autores principales: | Li, Aiyun, Guan, Li, Su, Wanzhen, Zhao, Ning, Song, Xuwen, Wang, Jin, Tang, Xiaoxiao, Li, Weize, Jiao, Xiangying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9858527/ https://www.ncbi.nlm.nih.gov/pubmed/36651294 http://dx.doi.org/10.1080/14756366.2023.2166937 |
Ejemplares similares
-
Txnip Gene Knockout Ameliorated High-Fat Diet–Induced Cardiomyopathy Via Regulating Mitochondria Dynamics and Fatty Acid Oxidation
por: Li, Aiyun, et al.
Publicado: (2023) -
Design, Synthesis, and Antitumor Activity of Novel Quinazoline Derivatives
por: Wang, Liuchang, et al.
Publicado: (2017) -
Quinazoline derivatives: synthesis and bioactivities
por: Wang, Dan, et al.
Publicado: (2013) -
Design, synthesis, and cytotoxic evaluation of quinazoline derivatives bearing triazole-acetamides
por: Pedrood, Keyvan, et al.
Publicado: (2023) -
Synthesis Biological Evaluation of Quinazoline-4-thiones
por: Kubicová, Lenka, et al.
Publicado: (2003)